XLRN

Acceleron Pharma Inc.
XLRN

Overview Fund Activity
Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

242 hedge funds and large institutions have $4.6B invested in Acceleron Pharma Inc. in 2020 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 90 increasing their positions, 67 reducing their positions, and 27 closing their positions.

Holders
242
Holders Change
+25
Holders Change %
+11.52%
% of All Funds
4.97%
Holding in Top 10
5
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-44.44%
% of All Funds
0.1%
New
53
Increased
90
Reduced
67
Closed
27
Calls
$58.6M
Puts
$51.5M
Net Calls
+$7.04M
Net Calls Change
+$16.3M

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$448M
2
EAM
2
Eagle Asset Management
Florida
$86.4M
3
Ameriprise
3
Ameriprise
Minnesota
$37.3M
4
Artisan Partners
4
Artisan Partners
Wisconsin
$73.2M
5
Fiera Capital (Canada)
5
Fiera Capital (Canada)
Quebec, Canada
$27M

Top Sellers

1
BlackRock
1
BlackRock
New York
$423M
2
GPP
2
Great Point Partners
Connecticut
$5.53M
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$146M
4
Northern Trust
4
Northern Trust
Illinois
$22.9M
5
State Street
5
State Street
Massachusetts
$108M
Name Holding Trade Value Shares
Change 		Shares
Change %
GC
101
Guggenheim Capital
Illinois
$3.2M +$3.2M +33,611 New
WG
102
Winton Group
United Kingdom
$3.02M +$1.44M +15,138 +91%
AQR Capital Management
103
AQR Capital Management
Connecticut
$2.98M +$422K +4,431 +17%
ECM
104
ExodusPoint Capital Management
New York
$2.98M +$2.98M +31,242 New
Qube Research & Technologies (QRT)
105
Qube Research & Technologies (QRT)
United Kingdom
$2.79M +$1.7M +17,859 +156%
BBA
106
Baker Bros. Advisors
New York
$2.57M – – –
EWM
107
Evercore Wealth Management
New York
$2.4M -$95.3K -1,000 -4%
MAM
108
Martingale Asset Management
Massachusetts
$2.34M +$1.97M +20,707 +544%
Arrowstreet Capital
109
Arrowstreet Capital
Massachusetts
$2.32M +$2.32M +24,300 New
Aviva
110
Aviva
United Kingdom
$2.26M -$1.78M -18,680 -44%
Morgan Stanley
111
Morgan Stanley
New York
$2.22M -$366K -3,839 -14%
NRS
112
Neville Rodie & Shaw
New York
$2.19M – – –
AllianceBernstein
113
AllianceBernstein
Tennessee
$2.07M -$3.77M -39,596 -65%
Voloridge Investment Management
114
Voloridge Investment Management
Florida
$2.05M +$1.15M +12,023 +126%
Russell Investments Group
115
Russell Investments Group
United Kingdom
$2.02M -$1.3M -13,643 -39%
QI
116
QS Investors
New York
$2M – – –
PVI
117
Pura Vida Investments
New York
$1.94M -$5.36M -56,281 -73%
Allianz Asset Management
118
Allianz Asset Management
Germany
$1.91M -$472K -4,949 -20%
WIA
119
Wealthstreet Investment Advisors
Texas
$1.9M – – –
PIM
120
Platinum Investment Management
Australia
$1.89M -$294K -3,087 -13%
LP
121
LMR Partners
United Kingdom
$1.86M +$1.86M +19,521 New
BC
122
Birchview Capital
Vermont
$1.78M – – –
IBT
123
International Biotechnology Trust
United Kingdom
$1.73M – – –
EI
124
EAM Investors
California
$1.72M -$547K -5,745 -24%
Ohio Public Employees Retirement System (OPERS)
125
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.67M +$1.67M +17,515 New
3 4
5
6 7